Growth Metrics

Palisade Bio (PALI) Preferred Stock Liabilities (2020)

Palisade Bio has reported Preferred Stock Liabilities over the past 1 years, most recently at $9.5 million for Q4 2020.

  • Quarterly Preferred Stock Liabilities changed N/A to $9.5 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $9.5 million through Dec 2020, changed N/A year-over-year, with the annual reading at $9.5 million for FY2020, N/A changed from the prior year.
  • Preferred Stock Liabilities was $9.5 million for Q4 2020 at Palisade Bio.
  • Over five years, Preferred Stock Liabilities peaked at $9.5 million in Q4 2020 and troughed at $9.5 million in Q4 2020.